The United Arab Emirates has approved emergency use of Sinopharm’s protein-based COVID-19 vaccine and it will be available to the public as a booster dose starting January 2022, the health ministry said.
The vaccine will be produced and distributed by a joint venture between the UAE’s Group 42 and China National Biotec Group (CNBG), a unit of China National Pharmaceutical Group (Sinopharm), the ministry said in a statement on state media on Monday.
The approval came following a UAE-based study that included individuals who were previously vaccinated with two doses of Sinopharm CNBG’s inactivated vaccine, the ministry added.
The UAE, a federation of seven emirates, on Monday reported 1,732 new coronavirus cases and one death. Authorities, who do not give a breakdown for each emirate, said around 91 percent of the population of some 10 million had been fully vaccinated.
UAE announces 1,621 new COVID-19 cases, 585 recoveries, one death in last 24 hoursThe Ministry of Health and Prevention (MoHAP) announced on Saturday 1,621 new coronavirus cases over the past 24 hours, bringing the total number of ... Coronavirus
UAE reports over 1,800 COVID-19 cases, highest daily infections since JulyThe UAE reported the highest number of daily coronavirus cases in almost six months, as it recorded more than 1,800 infections on Sunday.The Ministry ... Coronavirus
UAE reports decline in daily COVID-19 cases, after six-month high in infectionsThere has been a slight decline in the number of daily UAE coronavirus cases – a day after recording a six month high in new infections.The Ministry ... Coronavirus